Urinary tract infection caused by community-acquired extended-spectrum β-lactamase-producing bacteria in infants

被引:25
作者
Kim, Yun Hee [1 ]
Yang, Eun Mi [1 ]
Kim, Chan Jong [1 ,2 ]
机构
[1] Chonnam Natl Univ Hosp, Gwangju, South Korea
[2] Chonnam Natl Univ, Med Sch, Gwangju, South Korea
关键词
Urinary tract infection; Antimicrobial resistance; beta-Lactamase; Risk factors; Infant; ESBL-PRODUCING BACTERIA; ESCHERICHIA-COLI; RISK-FACTORS; ANTIMICROBIAL RESISTANCE; KLEBSIELLA-PNEUMONIAE; NURSING-HOMES; CHILDREN; EPIDEMIOLOGY;
D O I
10.1016/j.jped.2016.06.009
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective: Urinary tract infection (UTI) caused by resistant strains of bacteria is increasingly prevalent in children. The aim of this study was to investigate the clinical characteristics and risk factors for UTI caused by community-acquired extended-spectrum p-lactamase (CA-ESBL)producing bacteria in infants. Methods: This was a retrospective study performed over 5 years in a single Korean center. Hospitalized infants with febrile UTI were enrolled and divided into two groups (CA-ESBL vs. CA non-ESBL UTI). The yearly prevalence was calculated. Baseline characteristics and clinical course such as fever duration, laboratory and radiological findings were compared between the two groups. Risk factors associated with the CA-ESBL UTI were investigated. Results: Among the enrolled infants (n = 185), 31 (17%) had CA-ESBL UTI. The yearly prevalence of ESBL of CA-ESBL UTI increased during the study (0% in 2010, 22.2% in 2015). Infants with CA-ESBL UTI had a longer duration of fever after initiating antibiotics (2.0 +/- 1.1 vs. 1.5 +/- 0.6 days, p= 0.020). Cortical defects on renal scan and early treatment failure were more frequent in CA-ESBL (64.5 vs. 42.2%, p = 0.023; 22.6 vs. 4.5%, p = 0.001). A logistic regression analysis revealed that urinary tract abnormalities and previous UTI were independent risk factors for CA-EBSL UTI (odds ratio, 2.7; p = 0.025; 10.3; p= 0.022). Conclusion: The incidence of UTI caused by ESBL-producing bacteria has increased in Korean infants. Recognition of the clinical course and risk factors for ESLB-producing UTI may help to determine appropriate guidelines for its management. (C) 2016 Published by Elsevier Editora Ltda. on behalf of Sociedade Brasileira de Pediatria.
引用
收藏
页码:260 / 266
页数:7
相关论文
共 30 条
[1]   Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases [J].
Calbo, E ;
Romaní, V ;
Xercavins, M ;
Gómez, L ;
Vidal, CG ;
Quintana, S ;
Vila, J ;
Garau, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) :780-783
[2]   Antibiotic Resistance Patterns of Community-Acquired Urinary Tract Infections in Children With Vesicoureteral Reflux Receiving Prophylactic Antibiotic Therapy [J].
Cheng, Chi-Hui ;
Tsai, Ming-Horng ;
Huang, Yhu-Chering ;
Su, Lin-Hui ;
Tsau, Yong-Kwei ;
Lin, Chi-Jen ;
Chiu, Cheng-Hsun ;
Lin, Tzou-Yien .
PEDIATRICS, 2008, 122 (06) :1212-1217
[3]  
Coque TM, 2008, EUROSURVEILLANCE, V1, P3
[4]   Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children [J].
Fan, Nai-Chia ;
Chen, Hsin-Hang ;
Chen, Chyi-Liang ;
Ou, Liang-Shiou ;
Lin, Tzou-Yien ;
Tsai, Ming-Han ;
Chiu, Cheng-Hsun .
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2014, 47 (05) :399-405
[5]   Emergence of High Levels of Extended-Spectrum-β-Lactamase-Producing Gram-Negative Bacilli in the Asia-Pacific Region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program, 2007 [J].
Hawser, Stephen P. ;
Bouchillon, Samuel K. ;
Hoban, Daryl J. ;
Badal, Robert E. ;
Hsueh, Po-Ren ;
Paterson, David L. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (08) :3280-3284
[6]   Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children [J].
Kizilca, Ozgur ;
Siraneci, Rengin ;
Yilmaz, Alev ;
Hatipoglu, Nevin ;
Ozturk, Erkut ;
Kiyak, Aysel ;
Ozkok, Dilek .
PEDIATRICS INTERNATIONAL, 2012, 54 (06) :858-862
[7]   TRANSFERABLE RESISTANCE TO CEFOTAXIME, CEFOXITIN, CEFAMANDOLE AND CEFUROXIME IN CLINICAL ISOLATES OF KLEBSIELLA-PNEUMONIAE AND SERRATIA-MARCESCENS [J].
KNOTHE, H ;
SHAH, P ;
KRCMERY, V ;
ANTAL, M ;
MITSUHASHI, S .
INFECTION, 1983, 11 (06) :315-317
[8]   Risks Factors for Infections with Extended-Spectrum Beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae at a Tertiary Care University Hospital in Switzerland [J].
Kuster, S. P. ;
Hasse, B. ;
Huebner, V. ;
Bansal, V. ;
Zbinden, R. ;
Ruef, C. ;
Ledergerber, B. ;
Weber, R. .
INFECTION, 2010, 38 (01) :33-40
[9]  
LEVITT SB, 1981, PEDIATRICS, V67, P392
[10]   Defining an extended-spectrum β-lactamase [J].
Livermore, D. M. .
CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 :3-10